These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21098645)

  • 1. Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells.
    Zhang H; Tolonen A; Rousu T; Hirvonen J; Finel M
    Drug Metab Dispos; 2011 Mar; 39(3):456-64. PubMed ID: 21098645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of most UDP-glucuronosyltransferases (UGTs) is increased significantly during Caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells.
    Siissalo S; Zhang H; Stilgenbauer E; Kaukonen AM; Hirvonen J; Finel M
    Drug Metab Dispos; 2008 Nov; 36(11):2331-6. PubMed ID: 18694909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronidation of zearalenone, zeranol and four metabolites in vitro: formation of glucuronides by various microsomes and human UDP-glucuronosyltransferase isoforms.
    Pfeiffer E; Hildebrand A; Mikula H; Metzler M
    Mol Nutr Food Res; 2010 Oct; 54(10):1468-76. PubMed ID: 20397195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
    Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
    Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay.
    Di Marco A; D'Antoni M; Attaccalite S; Carotenuto P; Laufer R
    Drug Metab Dispos; 2005 Jun; 33(6):812-9. PubMed ID: 15788539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.
    Fisher MB; Campanale K; Ackermann BL; VandenBranden M; Wrighton SA
    Drug Metab Dispos; 2000 May; 28(5):560-6. PubMed ID: 10772635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucuronosyltransferase isoforms.
    Al-Zoughool M; Talaska G
    J Appl Toxicol; 2006; 26(6):524-32. PubMed ID: 17080401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
    Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
    Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
    Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
    Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
    Aprile S; Del Grosso E; Grosa G
    Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.
    Chen M; LeDuc B; Kerr S; Howe D; Williams DA
    Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
    Nakamori F; Naritomi Y; Hosoya K; Moriguchi H; Tetsuka K; Furukawa T; Kadono K; Yamano K; Terashita S; Teramura T
    Drug Metab Dispos; 2012 Sep; 40(9):1771-7. PubMed ID: 22685216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
    Hoehle SI; Pfeiffer E; Metzler M
    Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
    Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
    Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
    Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
    Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative importance of intestinal and hepatic glucuronidation-impact on the prediction of drug clearance.
    Cubitt HE; Houston JB; Galetin A
    Pharm Res; 2009 May; 26(5):1073-83. PubMed ID: 19184618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.